
Venture capital · Est. 2017
Pivotal Life Sciences
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Pivotal Life Sciences right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Pivotal Life Sciences joined, from press and the firm’s own posts.
Every round Pivotal Life Sciences joined
Round sizes, Pivotal Life Sciences’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Pivotal Life Sciences backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Pivotal Life Sciences
Events where Pivotal Life Sciences’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Pivotal Life Sciences is based in San Francisco, United States. It also has offices in Boston, Shanghai and Hong Kong.
In 2017.
2 fund vehicles are on public registers (SEC adviser filings), including PIVOTAL BIOVENTURE PARTNERS FUND II, L.P. and PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.
Sectors: Biotech, Life sciences. From the firm’s own website.
The firm invests across company stages with a primary focus on high-impact therapeutics that address growing unmet medical needs and offer transformative or near-curative potential. It targets companies approaching a major de-risking inflection point and works with management on company building. From the firm’s own website.
Pivotal Life Sciences lists 39 portfolio companies on its website, including Addition Therapeutics, Akouos, Inc., Aligos Therapeutics, Alkahest, A Grifols Company and Anthos Therapeutics.
Firms whose websites list some of the same companies include RA Capital, ARCH Venture Partners and Atlas Venture.
Know before Pivotal Life Sciences’s next round is announced.
PRO tracks Pivotal Life Sciences’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.